2019
DOI: 10.1016/j.ejpb.2018.04.007
|View full text |Cite
|
Sign up to set email alerts
|

3D printed, controlled release, tritherapeutic tablet matrix for advanced anti-HIV-1 drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
13
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3
3
2

Relationship

0
8

Authors

Journals

citations
Cited by 56 publications
(13 citation statements)
references
References 46 publications
0
13
0
Order By: Relevance
“…Chemically, emtricitabine (ECT) is 5-fluoro-1-(2R,5S)- [2-(hydroxymethyl It is a potential inhibitor of human immunodeficiency virus type I (HIV-I) reverse transcriptase and, hence, found to be effective against HIV-I infected patients [1,3]. ECT is prescribed to treat HIV-I infected patients either alone or in combination with other antiviral agents [3][4][5]. ECT is marketed It is a potential inhibitor of human immunodeficiency virus type I (HIV-I) reverse transcriptase and, hence, found to be effective against HIV-I infected patients [1,3].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Chemically, emtricitabine (ECT) is 5-fluoro-1-(2R,5S)- [2-(hydroxymethyl It is a potential inhibitor of human immunodeficiency virus type I (HIV-I) reverse transcriptase and, hence, found to be effective against HIV-I infected patients [1,3]. ECT is prescribed to treat HIV-I infected patients either alone or in combination with other antiviral agents [3][4][5]. ECT is marketed It is a potential inhibitor of human immunodeficiency virus type I (HIV-I) reverse transcriptase and, hence, found to be effective against HIV-I infected patients [1,3].…”
Section: Introductionmentioning
confidence: 99%
“…The potential of PEG-400 has been studied extensively in solubility enhancement of various drugs [9][10][11][12][13][14][15][16][17][18]. Several formulation approaches including "3D printed controlled release tablets [4], film coated tablets [19], rapidly disintegrating vaginal tablets [20], immediate release tablets [21], vaginal gels [22], liposomal gels [23], microparticulate drug delivery system [24], nanosuspensions [25,26] and polymeric nanoparticles [5,27,28]" were reported to improve antiviral therapy and pharmacokinetic profile of ECT. The equilibrium solubility of ECT in water was found as 112 mg mL −1 at "T = 298.2 K" [1].…”
Section: Introductionmentioning
confidence: 99%
“…El Aita et al investigated the drying process and found only 3 h of drying at 200 mbar in a vacuum dryer was sufficient for the complete drying (loss on drying, LOD, <1%) of their printed structure [148]. Other drying conditions reported as using a vacuum dryer at 40 • C for 24 h [18,76,139], on the heated printing platform at 80 • C for 3 h [149], in an oven at 40 • C for 12 h [150,151], left at 20 • C for 12 h [152], in an incubator containing a silica gel bead cartridge at 40 • C for 24 h [63] etc. Drying effect on structure and properties of the finished products are reported as during the drying process shell formation may occur on the outer surface of the tablet which might cause inefficient drying and result in the mechanical properties (friability, hardness) of the tablet [148], deformation of the structure [63,76,150], formation of pores on the surface [152], paste shrinkage [139], etc.…”
Section: Dosage Shape Size Complexitymentioning
confidence: 99%
“…Pierre Kondiah (University of the Witwatersrand, Johannesburg, South Africa) presented the significance of personalized 3D printed oral tablets for overcoming the limitations of conventional tablet fabrication approaches, as well as specifically tailoring drug delivery particularly where a patient response to the same drugs is varied [69][70][71][72]. 3D printing is rapidly forging its niche as an advanced and transformative build technology holding significant application in pharmaceutical sciences for creating bioinspired solid 3D devices from a digital model with customizable, complex shapes, surfaces, and architectures employing diverse materials.…”
Section: Bioprintingmentioning
confidence: 99%
“…The addition of anti-inflammatory agents to the 3D bioink scaffolds provides acute treatment of specific inflammation and support for adequate tissue repair and rehabilitation. The specific prepared scaffold, PCL-PVA-PAA (PPP), experienced load bearing tissue repair where inflammation was prevalent [70].…”
Section: Bioprintingmentioning
confidence: 99%